Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Togashi

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 18, 2020
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancerAkinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
Cancer Research|April 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingYuto Naoi, Takao Morinaga, Joji Nagasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
The Journal of Clinical Investigation|April 1, 2024
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockadeHidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, et al.
Communications Biology|December 16, 2025
Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinomaAtsushi Matsuoka, Kazuhiko Shien, Shuta Tomida, et al.
Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytesHiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 18, 2020
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancerAkinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
Cancer Research|April 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingYuto Naoi, Takao Morinaga, Joji Nagasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
The Journal of Clinical Investigation|April 1, 2024
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockadeHidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, et al.
Communications Biology|December 16, 2025
Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinomaAtsushi Matsuoka, Kazuhiko Shien, Shuta Tomida, et al.
Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytesHiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
Pageof 16